Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359101 (US10220048, Compound AA11 | US10952992, No. AA11 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0100 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Non-limiting examples of the HPTPβ IC50 (μM) activity. | Citation and Details BindingDB Entry DOI: 10.7270/Q2668HD5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359101 (US10220048, Compound AA11 | US10952992, No. AA11 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0100 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO PHARMACEUTICALS, INC. US Patent | Assay Description Non-limiting examples of the HPTP-β IC50 (μM) activity. | US Patent US10952992 (2021) BindingDB Entry DOI: 10.7270/Q2FR00R3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359101 (US10220048, Compound AA11 | US10952992, No. AA11 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0100 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO THERAPEUTICS, INC. US Patent | Assay Description HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N... | US Patent US10220048 (2019) BindingDB Entry DOI: 10.7270/Q2VT1VC9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359101 (US10220048, Compound AA11 | US10952992, No. AA11 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | n/a | n/a | 0.0100 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2RV0SPJ | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359121 (US10220048, Compound AA31 | US10952992, No. AA31 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0800 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Non-limiting examples of the HPTPβ IC50 (μM) activity. | Citation and Details BindingDB Entry DOI: 10.7270/Q2668HD5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359106 (US10220048, Compound AA16 | US10952992, No. AA16 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0800 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Non-limiting examples of the HPTPβ IC50 (μM) activity. | Citation and Details BindingDB Entry DOI: 10.7270/Q2668HD5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359121 (US10220048, Compound AA31 | US10952992, No. AA31 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0800 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO PHARMACEUTICALS, INC. US Patent | Assay Description Non-limiting examples of the HPTP-β IC50 (μM) activity. | US Patent US10952992 (2021) BindingDB Entry DOI: 10.7270/Q2FR00R3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359106 (US10220048, Compound AA16 | US10952992, No. AA16 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0800 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO PHARMACEUTICALS, INC. US Patent | Assay Description Non-limiting examples of the HPTP-β IC50 (μM) activity. | US Patent US10952992 (2021) BindingDB Entry DOI: 10.7270/Q2FR00R3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359121 (US10220048, Compound AA31 | US10952992, No. AA31 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0800 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO THERAPEUTICS, INC. US Patent | Assay Description HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N... | US Patent US10220048 (2019) BindingDB Entry DOI: 10.7270/Q2VT1VC9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359106 (US10220048, Compound AA16 | US10952992, No. AA16 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0800 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO THERAPEUTICS, INC. US Patent | Assay Description HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N... | US Patent US10220048 (2019) BindingDB Entry DOI: 10.7270/Q2VT1VC9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359121 (US10220048, Compound AA31 | US10952992, No. AA31 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | n/a | n/a | 0.0800 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2RV0SPJ | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359106 (US10220048, Compound AA16 | US10952992, No. AA16 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | n/a | n/a | 0.0800 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2RV0SPJ | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359113 (US10220048, Compound AA23 | US10952992, No. AA23 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0900 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO THERAPEUTICS, INC. US Patent | Assay Description HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N... | US Patent US10220048 (2019) BindingDB Entry DOI: 10.7270/Q2VT1VC9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359113 (US10220048, Compound AA23 | US10952992, No. AA23 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0900 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO PHARMACEUTICALS, INC. US Patent | Assay Description Non-limiting examples of the HPTP-β IC50 (μM) activity. | US Patent US10952992 (2021) BindingDB Entry DOI: 10.7270/Q2FR00R3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359113 (US10220048, Compound AA23 | US10952992, No. AA23 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | n/a | n/a | 0.0900 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2RV0SPJ | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359113 (US10220048, Compound AA23 | US10952992, No. AA23 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0900 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Non-limiting examples of the HPTPβ IC50 (μM) activity. | Citation and Details BindingDB Entry DOI: 10.7270/Q2668HD5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359099 (US10220048, Compound AA9 | US10952992, No. AA9 | U...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO PHARMACEUTICALS, INC. US Patent | Assay Description Non-limiting examples of the HPTP-β IC50 (μM) activity. | US Patent US10952992 (2021) BindingDB Entry DOI: 10.7270/Q2FR00R3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359118 (US10220048, Compound AA28 | US10952992, No. AA28 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2RV0SPJ | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359104 (US10220048, Compound AA14 | US10952992, No. AA14 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO PHARMACEUTICALS, INC. US Patent | Assay Description Non-limiting examples of the HPTP-β IC50 (μM) activity. | US Patent US10952992 (2021) BindingDB Entry DOI: 10.7270/Q2FR00R3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359118 (US10220048, Compound AA28 | US10952992, No. AA28 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Non-limiting examples of the HPTPβ IC50 (μM) activity. | Citation and Details BindingDB Entry DOI: 10.7270/Q2668HD5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359104 (US10220048, Compound AA14 | US10952992, No. AA14 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO THERAPEUTICS, INC. US Patent | Assay Description HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N... | US Patent US10220048 (2019) BindingDB Entry DOI: 10.7270/Q2VT1VC9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359104 (US10220048, Compound AA14 | US10952992, No. AA14 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Non-limiting examples of the HPTPβ IC50 (μM) activity. | Citation and Details BindingDB Entry DOI: 10.7270/Q2668HD5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359099 (US10220048, Compound AA9 | US10952992, No. AA9 | U...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO THERAPEUTICS, INC. US Patent | Assay Description HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N... | US Patent US10220048 (2019) BindingDB Entry DOI: 10.7270/Q2VT1VC9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359118 (US10220048, Compound AA28 | US10952992, No. AA28 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO PHARMACEUTICALS, INC. US Patent | Assay Description Non-limiting examples of the HPTP-β IC50 (μM) activity. | US Patent US10952992 (2021) BindingDB Entry DOI: 10.7270/Q2FR00R3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359099 (US10220048, Compound AA9 | US10952992, No. AA9 | U...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Non-limiting examples of the HPTPβ IC50 (μM) activity. | Citation and Details BindingDB Entry DOI: 10.7270/Q2668HD5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359118 (US10220048, Compound AA28 | US10952992, No. AA28 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO THERAPEUTICS, INC. US Patent | Assay Description HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N... | US Patent US10220048 (2019) BindingDB Entry DOI: 10.7270/Q2VT1VC9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359104 (US10220048, Compound AA14 | US10952992, No. AA14 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2RV0SPJ | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359099 (US10220048, Compound AA9 | US10952992, No. AA9 | U...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2RV0SPJ | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359117 (US10220048, Compound AA27 | US10952992, No. AA27 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | n/a | n/a | 0.140 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2RV0SPJ | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359117 (US10220048, Compound AA27 | US10952992, No. AA27 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.140 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO THERAPEUTICS, INC. US Patent | Assay Description HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N... | US Patent US10220048 (2019) BindingDB Entry DOI: 10.7270/Q2VT1VC9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359117 (US10220048, Compound AA27 | US10952992, No. AA27 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.140 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO PHARMACEUTICALS, INC. US Patent | Assay Description Non-limiting examples of the HPTP-β IC50 (μM) activity. | US Patent US10952992 (2021) BindingDB Entry DOI: 10.7270/Q2FR00R3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359117 (US10220048, Compound AA27 | US10952992, No. AA27 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.140 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Non-limiting examples of the HPTPβ IC50 (μM) activity. | Citation and Details BindingDB Entry DOI: 10.7270/Q2668HD5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359091 (US10220048, Compound AA1 | US10220048, Compound AA...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | n/a | n/a | 0.157 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2RV0SPJ | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359091 (US10220048, Compound AA1 | US10220048, Compound AA...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.157 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Non-limiting examples of the HPTPβ IC50 (μM) activity. | Citation and Details BindingDB Entry DOI: 10.7270/Q2668HD5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359091 (US10220048, Compound AA1 | US10220048, Compound AA...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.157 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO PHARMACEUTICALS, INC. US Patent | Assay Description Non-limiting examples of the HPTP-β IC50 (μM) activity. | US Patent US10952992 (2021) BindingDB Entry DOI: 10.7270/Q2FR00R3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359091 (US10220048, Compound AA1 | US10220048, Compound AA...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.157 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO THERAPEUTICS, INC. US Patent | Assay Description HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N... | US Patent US10220048 (2019) BindingDB Entry DOI: 10.7270/Q2VT1VC9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359096 (US10220048, Compound AA6 | US10952992, No. AA6 | U...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | n/a | n/a | 0.162 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2RV0SPJ | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359096 (US10220048, Compound AA6 | US10952992, No. AA6 | U...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.162 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Non-limiting examples of the HPTPβ IC50 (μM) activity. | Citation and Details BindingDB Entry DOI: 10.7270/Q2668HD5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359096 (US10220048, Compound AA6 | US10952992, No. AA6 | U...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.162 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO PHARMACEUTICALS, INC. US Patent | Assay Description Non-limiting examples of the HPTP-β IC50 (μM) activity. | US Patent US10952992 (2021) BindingDB Entry DOI: 10.7270/Q2FR00R3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359096 (US10220048, Compound AA6 | US10952992, No. AA6 | U...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.162 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO THERAPEUTICS, INC. US Patent | Assay Description HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N... | US Patent US10220048 (2019) BindingDB Entry DOI: 10.7270/Q2VT1VC9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359120 (US10220048, Compound AA30 | US10952992, No. AA30 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.200 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Non-limiting examples of the HPTPβ IC50 (μM) activity. | Citation and Details BindingDB Entry DOI: 10.7270/Q2668HD5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359108 (US10220048, Compound AA18 | US10952992, No. AA18 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.200 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Non-limiting examples of the HPTPβ IC50 (μM) activity. | Citation and Details BindingDB Entry DOI: 10.7270/Q2668HD5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359187 (US10220048, Compound AA97 | US10952992, No. AA97 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.200 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Non-limiting examples of the HPTPβ IC50 (μM) activity. | Citation and Details BindingDB Entry DOI: 10.7270/Q2668HD5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359178 (US10220048, Compound AA88 | US10952992, No. AA88 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | n/a | n/a | 0.200 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2RV0SPJ | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359187 (US10220048, Compound AA97 | US10952992, No. AA97 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | n/a | n/a | 0.200 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2RV0SPJ | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359100 (US10220048, Compound AA10 | US10952992, No. AA10 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | n/a | n/a | 0.200 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2RV0SPJ | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359108 (US10220048, Compound AA18 | US10952992, No. AA18 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | n/a | n/a | 0.200 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2RV0SPJ | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359120 (US10220048, Compound AA30 | US10952992, No. AA30 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | n/a | n/a | 0.200 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2RV0SPJ | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359100 (US10220048, Compound AA10 | US10952992, No. AA10 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.200 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO THERAPEUTICS, INC. US Patent | Assay Description HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N... | US Patent US10220048 (2019) BindingDB Entry DOI: 10.7270/Q2VT1VC9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein phosphatase beta (Homo sapiens (Human)) | BDBM359108 (US10220048, Compound AA18 | US10952992, No. AA18 |...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 0.200 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO THERAPEUTICS, INC. US Patent | Assay Description HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N... | US Patent US10220048 (2019) BindingDB Entry DOI: 10.7270/Q2VT1VC9 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 479 total ) | Next | Last >> |